Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Gap Up – Time to Buy?

Ono Pharmaceutical Co. (OTCMKTS:OPHLF)’s share price gapped up prior to trading on Friday . The stock had previously closed at $13.38, but opened at $15.33. Ono Pharmaceutical shares last traded at $14.61, with a volume of 911 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised shares of Ono Pharmaceutical from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 13th. One analyst has rated the stock with a Strong Buy rating, According to data from MarketBeat.com, Ono Pharmaceutical presently has an average rating of “Strong Buy”.

Ono Pharmaceutical Stock Up 9.2%

The company has a debt-to-equity ratio of 0.10, a quick ratio of 2.56 and a current ratio of 3.02. The business has a 50 day simple moving average of $14.32 and a 200-day simple moving average of $14.73. The firm has a market capitalization of $6.87 billion, a price-to-earnings ratio of 14.76 and a beta of 0.34.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., founded in 1717 and headquartered in Osaka, Japan, is a research‐based pharmaceutical company specializing in the discovery, development and marketing of innovative therapies. With origins as a traditional pharmacy, Ono has grown into a global biopharmaceutical entity focused on delivering new treatment options across several therapeutic areas, including oncology, immunology, cardiovascular and antiviral diseases. The company conducts comprehensive research programs spanning early drug discovery through to clinical development.

One of Ono’s most recognized products is the immune checkpoint inhibitor nivolumab, marketed in collaboration with Bristol-Myers Squibb under the trade name Opdivo.